Clinical Trial Update: Disease Biosignatures in ALS/FTD Spectrum: New Impactful Biological Perspectives Beyond Clinical Approaches

View source ↗

Summary

A clinical trial investigating disease biosignatures in the ALS/FTD spectrum, exploring biological perspectives beyond traditional clinical approaches; currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis
• Frontotemporal Dementia

Snippet

Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | Conditions: ALS (Amyotrophic Lateral Sclerosis), FTD | Status: RECRUITING